C2-ceramide also reduces the pro-survival proteins Akt and NFκB, causing the down-regulation of survivin and cyclin A2, which are reported to frequently overexpress in non-small cell lung cancer[35]. The gene discussed is NFKB1; the disease is non-small cell lung carcinoma.